# Healthpeak Properties, Inc.: Form 10-Q for the period ended Sep 30, 2015

- Company: [Healthpeak Properties, Inc.](/companies/doc.md) (CIK 765880)
- Form: 10-Q
- Filed: 2015-11-03
- Accepted by EDGAR: Nov 3, 2015, 08:41 ET
- Period: 2015-09-30
- Accession: 0001558370-15-002147
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/765880/000155837015002147/hcp-20150930x10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/765880/000155837015002147/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2015-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2015-07-01 to 2015-09-30 | $658.0m | us-gaap:Revenues |
| Revenue | 9 months, 2015-01-01 to 2015-09-30 | $1.88bn | us-gaap:Revenues |
| Interest expense | 3 months, 2015-07-01 to 2015-09-30 | $122.2m | us-gaap:InterestExpense |
| Interest expense | 9 months, 2015-01-01 to 2015-09-30 | $357.6m | us-gaap:InterestExpense |
| Income tax | 3 months, 2015-07-01 to 2015-09-30 | −$2.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2015-01-01 to 2015-09-30 | −$6.6m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2015-07-01 to 2015-09-30 | $115.4m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2015-01-01 to 2015-09-30 | $39.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2015-07-01 to 2015-09-30 | $0.25 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2015-01-01 to 2015-09-30 | $0.08 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2015-07-01 to 2015-09-30 | $0.25 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2015-01-01 to 2015-09-30 | $0.08 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2015-07-01 to 2015-09-30 | 463,586,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2015-01-01 to 2015-09-30 | 462,302,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2015-01-01 to 2015-09-30 | $867.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2015-01-01 to 2015-09-30 | $253.9m | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 9 months, 2015-01-01 to 2015-09-30 | $783.6m | us-gaap:PaymentsOfDividends |
| Share repurchases | 9 months, 2015-01-01 to 2015-09-30 | $8.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2015-09-30 | $120.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Total assets | at 2015-09-30 | $22.19bn | us-gaap:Assets |
| Total liabilities | at 2015-09-30 | $11.73bn | us-gaap:Liabilities |
| Long-term debt | at 2015-09-30 | $11.05bn | us-gaap:LongTermDebt |
| Shareholders' equity | at 2015-09-30 | $10.17bn | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 92,679 characters.

### Cautionary Language Regarding Forward-Looking Statements

Statements in this Quarterly Report on Form 10-Q that are not historical factual statements are “forward-looking statements.” We intend to have our forward-looking statements covered by the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and include this statement for purposes of complying with those provisions. Forward-looking statements include, among other things, statements regarding our and our officers’ intent, belief or expectation as identified by the use of words such as “may,” “will,” “project,” “expect,” “believe,” “intend,” “anticipate,” “seek,” “forecast,” “plan,” “potential,” “estimate,” “could,” “would,” “should” and other comparable and derivative terms or the negatives thereof. Any such forward-looking statements reflect our current expectations and views about future events and are subject to a number of risks and uncertainties that could significantly affect the Company’s future financial condition and results of operations. While forward-looking statements reflect our good faith belief and reasonable assumptions based upon current information, we can give no assurance that our expectations or forecasts will be attained. Further, we cannot guarantee the accuracy of any such forward-looking statement contained in this Quarterly Report, and such forward-looking statements are subject to known and unknown risks and uncertainties that are difficult to predict. As more fully set forth under Part I, Item 1A. “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2014, as updated by Part II, Item 1A. “Risk Factors” in our Quarterly Report on Form 10-Q for the quarter ended March 31, 2015, risks and uncertainties that may cause our actual results to differ materially from the expectations contained in the forward-looking statements include, among other things:

(a) our ability to fully evaluate HCR ManorCare, Inc.’s (“HCRMC”) ability to meet its contractual obligations under the HCRMC Lease Amendment and risks related to the impact of the United States (“U.S.”) Department of Justice lawsuit against HCRMC, including the possibility of larger than expected litigation costs, adverse results and related developments;

(b) our reliance on a concentration of a small number of tenants and operators for a significant portion of our revenues;

(c) the financial weakness of tenants and operators, including potential bankruptcies, significant litigation exposure and downturns in their businesses, which results in uncertainties regarding our ability to continue to realize the full benefit of such tenants’ and/or operators’ leases or loans;

(d) the ability of our tenants and operators to conduct their respective businesses in a manner sufficient to maintain or increase their revenues and to generate sufficient income to make rent and loan payments to us and our ability to recover investments made, if applicable, in their operations;

(e) competition for tenants and operators, including with respect to new leases and mortgages and the renewal or rollover of existing leases;

(f) availability of suitable properties to acquire at favorable prices and the competition for the acquisition and financing of those properties;

(g) our ability to negotiate the same or better terms with new tenants or operators if existing leases are not renewed or we exercise our right to replace an existing tenant or operator upon default;

(h) the risks associated with our investments in joint ventures and unconsolidated entities, including our lack of sole decision making authority and our reliance on our partners’ financial condition and continued cooperation;

(i) the risk that we may not be able to achieve the benefits of investments within expected time frames or at all, or within expected cost projections;

(j) the potential impact of future litigation matters, including the possibility of larger than expected litigation costs, adverse results and related developments;

(k) the effect on healthcare providers of legislation addressing entitlement programs and related services, including Medicare and Medicaid, which may result in future reductions in reimbursements;

(l) changes in federal, state or local laws and regulations, including those affecting the healthcare industry that affect our costs of compliance or increase the costs, or otherwise affect the operations, of our tenants and operators;

(m) volatility or uncertainty in the capital markets, the availability and cost of capital as impacted by interest rates, changes in our credit ratings, and the value of our common stock, and other conditions that may adversely impact our ability to fund our obligations or consummate transactions, or reduce the earnings from potential transactions;

(n) changes in global, national and local economic conditions, and currency exchange rates;

(o) changes in the credit ratings on U.S. government debt securities or default or delay in payment by the U.S. of its obligations;

(p) our ability to manage our indebtedness level and changes in the terms of such indebtedness; and

(q) the ability to maintain our qualification as a real estate investment trust (“REIT”).

Except as required by law, we undertake no, and hereby disclaim any, obligation to update any forward-looking statements, whether as a result of new information, changed circumstances or otherwise.

The information set forth in this Item 2 is intended to provide readers with an understanding of our financial condition, changes in financial condition and results of operations. We will discuss and provide our analysis in the following order:

- Executive Summary
- 2015 Transaction Overview
- Dividends
- Results of Operations
- Liquidity and Capital Resources
- Contractual Obligations
- Off-Balance Sheet Arrangements
- Inflation
- Non-GAAP Financial Measures Reconciliations
- Critical Accounting Policies
- Recent Accounting Pronouncements

### Executive Summary

HCP, Inc., a Standard & Poor’s (“S&P”) 500 company, invests primarily in real estate serving the healthcare industry in the United States. We are a Maryland corporation organized in 1985 and qualify as a self-administered REIT. We acquire, develop, lease, manage and dispose of healthcare real estate, and provide financing to healthcare providers. At September 30, 2015, our portfolio of investments, including properties in our unconsolidated joint ventures, consisted of interests in 1,279 facilities.

We invest and manage our real estate portfolio for the long-term to maximize the benefit to our stockholders and support the growth of our dividends. The core elements of our strategy are: (i) to acquire, develop, lease, own and manage a diversified portfolio of quality healthcare properties across multiple business segments and geographic locations (including Europe); (ii) to align ourselves with leading healthcare companies, operators and service providers, which over the long-term should result in higher relative rental rates, net operating cash flows and appreciation of property values; (iii) to concentrate on longer-term escalating triple-net leases with high-quality tenants, while using RIDEA structures for properties that have higher growth potential; (iv) to maintain adequate liquidity with long-term fixed rate debt financing with staggered maturities, which supports the longer-term nature of our investments, while reducing our exposure to interest rate volatility and refinancing risk at any point in the interest rate or credit cycles; and (v) to continue to manage our balance sheet with a targeted financial leverage of approximately 40% relative to our assets.

We believe that our longer-term escalating triple-net leases with financially strong tenants and operators enhance the quality, stability and growth of our rental income. Further, we believe many of our existing properties hold the potential for increased future cash flows due to their high quality and desirable locations within markets where the creation of new supply is limited by the lack of available sites and the difficulty of obtaining the necessary licensing, other approvals and/or financing. Our strategy for maximizing the benefits from these opportunities is to: (i) work with new or existing tenants and operators to address their space and capital needs and (ii) provide high-quality property management services in order to motivate tenants to renew, expand or relocate into our properties.

The delivery of healthcare services requires real estate and, as a result, tenants and operators depend on real estate, in part, to maintain and grow their businesses. We believe that the healthcare real estate market provides investment opportunities due to the: (i) compelling demographics driving the demand for healthcare services; (ii) specialized nature of healthcare real estate investing; and (iii) ongoing consolidation of the fragmented healthcare real estate sector.

While we emphasize healthcare real estate ownership, we may also provide real estate secured financing to, or invest in equity or debt securities of, healthcare operators or other entities engaged in healthcare real estate ownership. We may also acquire all or substantially all of the securities or assets of other REITs, operating companies or similar entities where such investments would be consistent with our investment strategies. We may co-invest alongside institutional or development investors through partnerships or limited liability companies.

We monitor, but do not limit, our investments based on the percentage of our total assets that may be invested in any one property type, investment vehicle or geographic location, the number of properties that may be leased to a single tenant or operator, or loans that may be made to a single borrower. In allocating capital to our multiple segments, we target opportunities with the most attractive risk/reward profile for our portfolio as a whole. We may take additional measures to mitigate risk, including diversifying our investments (by sector, geography, tenant or operator), structuring transactions as master leases, requiring tenant or operator insurance and indemnifications, and obtaining credit enhancements in the form of guarantees, letters of credit or security deposits.

Because our REIT qualification requires us to distribute at least 90% of our REIT taxable income (excluding net capital gains), we regularly access the public equity and debt markets to raise the funds necessary to finance acquisitions and debt investments, develop and redevelop properties, and refinance maturing debt.

We maintain a conservative balance sheet by actively managing our debt to equity levels, using long-term fixed rate debt and staggering our contractual maturities. We also utilize multiple sources of capital including equity, unsecured bonds, revolving line of credit facilities, term loans, and secured debt. We have relationships with institutional joint venture partners which have been a source of capital for our joint ventures.

We evaluate multiple sources of capital when financing our investments. For debt investments, we may utilize our revolving line of credit facility or originate bank term loans. Typically we fund long term real estate investments with common stock and long term unsecured bonds. Additionally, in connection with joint ventures, we typically utilize non-recourse mortgage debt.

### 2015 Transaction Overview

#### HCR ManorCare, Inc.

During the three months ended March 31, 2015, HCP and HCR ManorCare, Inc. (“HCRMC”) agreed to market for sale the real estate and operations associated with 50 non-strategic facilities that are under the Master Lease and Security Agreement (the “Master Lease”) for an estimated total gross sales price of approximately $350 million. HCRMC will receive an annual rent reduction under the Master Lease based on 7.75% of the net sales proceeds received by HCP. Through November 2, 2015, 12 of the facility sales have closed and the remaining facility sales are expected to occur during the fourth quarter of 2015 and the first quarter of 2016.

Additionally, in March 2015, HCP and HCRMC agreed to amend the Master Lease (the “HCRMC Lease Amendment”). Commencing April 1, 2015, HCP provided an annual net rent reduction of $68 million, which equates to initial lease year rent of $473 million, compared to $541 million that would have commenced April 1, 2015 prior to the HCRMC Lease

Amendment. The contractual rent will increase by 3.0% annually during the initial term. In exchange, HCP will receive the following consideration:

- Fee ownership in nine post-acute facilities valued at $275 million with a median age of four years, currently owned and operated by HCRMC. HCP will retain a lease receivable of equal value, earning income of $19 million annually (included in the amended initial lease year rent of $473 million above), which will be reduced as the facility purchases are completed. Following the purchase of a facility, HCRMC will lease such facility from the HCP pursuant to the Master Lease. The nine facilities will contribute an aggregate of $19 million of annual rent (subject to escalation) under the Master Lease. Through November 2, 2015, HCRMC and HCP completed four of the nine facility purchases for $99 million. The purchases of the remaining five facilities are expected to occur by the end of the first quarter of 2016, subject to customary licensing and regulatory approvals;
- A second lease receivable with an initial amount of $250 million, payable by HCRMC upon the earlier of: (i) the end of the initial term of the first renewal pool under the HCRMC Lease Amendment, or (ii) certain capital or liquidity events of HCRMC, including an IPO or sale. The $250 million lease receivable amount will increase each year as follows: 3.0% in April 2016 through 2018, 4.0% in 2019, 5.0% in 2020 and 6.0% in 2021 until the end of the initial lease term; and
- Extension of the initial lease term by five years, to an average of 16 years.

In March 2015, we recorded a non-cash net impairment charge of $478 million related to our direct financing lease (“DFL”) investments with HCRMC. The non-cash charge reduced the carrying value of the HCRMC DFL investments from $6.6 billion to $6.1 billion, which represented the present value of the future lease payments under the HCRMC Lease Amendment. The impairment determination resulted from discussions with HCRMC in which they expressed an increasing desire to reduce rent in consideration of potential economic trades to HCP prior to the April 1, 2015 rental increase of 3.5% under the Master Lease (without regard to the HCRMC Lease Amendment). HCRMC indicated that they sought an amendment of the Master Lease to provide financial flexibility to meet the reimbursement and competitive challenges they face in operating and growing their business, and to remove any uncertainty that could result from any further deterioration in their operating results and corresponding ability to remain in compliance with the covenants under their credit facilities.

See Note 6 to the Consolidated Financial Statements for additional discussion on the HCRMC Lease Amendment and impairment of our HCRMC direct financing lease investment and Note 8 to the Consolidated Financial Statements for additional discussion regarding the U.S. Department of Justice complaint against HCRMC, which information is incorporated by reference herein.

On October 28, 2015, we concluded that our 9% equity investment in HCRMC was other-than-temporarily impaired as of September 30, 2015 and we recorded an impairment charge of $27 million during the third quarter of 2015. The impairment charge reduced the carrying amount of our equity investment in HCRMC to $21 million. Our impairment determination primarily resulted from our review of recent HCRMC operating results and market and industry data which, among other factors, show a declining trend in admissions from hospitals and continuing trends in mix and length of stay driven by Medicare Advantage and other managed care plans. Notwithstanding these developments, HCRMC’s financial information indicates that HCRMC will continue to meet its contractual obligations to HCP under the Master Lease as we expect the lease coverage to continue to improve due to the HCRMC Lease Amendment and sale of the 50 non-strategic facilities. Therefore, we continue to believe that the collection and timing of all amounts owed by HCRMC under our Master Lease are reasonably assured.

#### Acquisition of Private Pay Senior Housing Portfolio

On June 30, 2015, HCP and Brookdale Senior Living, Inc. (“Brookdale”) acquired a portfolio of 35 private pay senior housing communities from Chartwell Retirement Residences, including two leasehold interests, representing 5,025 units for $847 million. The portfolio was acquired in a RIDEA structure (RIDEA III), with Brookdale owning a 10% noncontrolling interest. Brookdale has operated these communities since 2011, and continues to manage the communities under a long-term management agreement.

#### The Cove Development

In February 2015, we began construction on the first phase, $177 million, of The Cove at Oyster Point (“The Cove”), a life science development in South San Francisco, California. The first phase includes two “class A” buildings totaling 253,000 square feet that are expected to be completed in the third quarter of 2016.

#### U.K. Investments

In February 2015, we increased our United Kingdom (“U.K.”) HC-One debt investment (“HC-One Facility”) by £108 million ($164 million) to £502 million ($795 million) in conjunction with HC-One’s acquisition of Meridian Healthcare. At closing, the HC-One Facility was secured by 303 nursing and residential care homes representing over 13,900 beds in the U.K., primarily located in England and Scotland.

In April 2015, we converted £174 million of our total £502 million HC-One Facility to fee ownership in a portfolio of 36 care homes subject to long-term triple-net leases that provide aggregate rent in the first year of £13 million. The contractual rent will increase annually by the Retail Price Index (“RPI”), with rent resets to fair market value at the end of lease years 15 and 25. The triple-net leases have initial terms of 30 years with lessee termination options at the end of lease years 15 and 25.

In May 2015, we provided a £27 million ($42 million) loan to fund Maria Mallaband Care Group’s (“Maria Mallaband”) acquisition of two care homes in the U.K. In July 2015, the loan was converted into fee ownership of the real estate at an equal value and the properties are triple-net leased to Maria Mallaband for an initial term of 15 years.

In September 2015, we amended and increased the commitment under our HC-One Facility by £11 million, primarily to fund a development project in the U.K. and other capital improvements.

#### Acquisitions of On-Campus Medical Office Buildings

In April 2015, we acquired a medical office building (“MOB”) in Philadelphia, Pennsylvania for $161 million. The MOB is anchored by Thomas Jefferson University Hospital, which is ranked 2nd among best hospitals in the Philadelphia metropolitan area by U.S. News and is owned by ‘A rated’ Thomas Jefferson University. The MOB contains 705,000 rentable square feet and was 85% occupied at closing.

In June 2015, we expanded our relationship with Memorial Hermann Health System (“Memorial Hermann”) through the acquisition of a portfolio of 11 on-campus MOBs located in Houston, Texas in a sale-leaseback transaction for $225 million. Memorial Hermann, an ‘A rated’ health system, is the largest not-for-profit system in Southeast Texas and maintains the largest market share at 24% in the Houston metro area. The MOB portfolio, located on four campuses, has an aggregate 1.2 million rentable square feet and is subject to triple-net master leases with 10-year initial lease terms and four 5-year renewal terms. In October 2015, we issued a 49% noncontrolling interest in this portfolio (“HCP Ventures V”) for $110 million.

In October 2015, we increased our ownership of the Nordstrom Medical Tower in Seattle, Washington to 116,800 square feet by acquiring two fully-occupied condominium units totaling 15,300 rentable square feet for $7 million.

#### MBK Joint Venture Transactions

In March 2015, we formed a new RIDEA joint venture (“MBK JV”) with MBK Senior Living (“MBK”), a subsidiary of Mitsui & Co. Ltd, that acquired three senior housing facilities for $126 million with HCP and MBK each owning a 50% equity interest. MBK manages these communities on behalf of this joint venture. At closing, we contributed $27 million of cash and MBK contributed the three senior housing facilities, which were encumbered by $78 million of mortgage debt. The MBK JV intends to acquire additional senior housing facilities by focusing on off-market transactions.

In September 2015, we formed a new development joint venture with MBK (“MBK Development JV”) which acquired a $3 million parcel of land for the purpose of developing a 74-unit class A senior housing facility in Santa Rosa, California. The parcel of land is located adjacent to the Oakmont Gardens independent living facility currently owned and operated by the MBK JV.

#### Other Investment Transactions

In March 2015, we exercised the purchase option under our $14 million par value development loan to acquire a newly built assisted living and memory care facility in Houston, Texas for $36 million. The facility was 99% occupied at closing and was placed in a RIDEA structure with Brookdale acquiring a 10% noncontrolling interest and managing the facility.

In April 2015, we exercised the purchase option under our $33 million par value development loan to acquire a newly built assisted living and memory care facility in Germantown, Tennessee for $72 million. The facility was 93% occupied at closing and was placed in a RIDEA structure with Brookdale acquiring a 10% noncontrolling interest and managing the facility.

In May 2015, we increased and extended our mezzanine loan facility with Tandem Health Care (“Tandem”) to (i) fund an additional $55 million, which proceeds were used to repay a portion of Tandem’s existing senior and mortgage debt tranches; (ii) extend its maturity to October 2018; and (iii) extend the prepayment penalty period to January 2017. The mezzanine loan facility now totals $256 million and has an 11.5% blended coupon, or 11.9% blended yield-to-maturity.

In August 2015, we expanded our senior housing joint venture partnership with Brookdale through the CCRC JV in an add-on expansion within one of its Florida communities for $30 million, of which our contribution was $8 million.

#### Financing and Capital Recycling Activities

In January 2015, we issued $600 million of 3.40% senior unsecured notes due 2025. The notes were priced at 99.185% of the principal amount with a yield-to-maturity of 3.497%. Net proceeds were used to repay the entire $105 million U.S. dollar amount outstanding on our revolving credit facility at closing and $200 million of 6.00% senior unsecured notes that matured on March 1, 2015. We used the remaining proceeds to repay $200 million of 7.07% senior unsecured notes maturing in June 2015 and for general corporate purposes.

In January 2015, to economically hedge a portion of our foreign currency risk from the HC-One Facility, we completed a £220 million four-year unsecured term loan that accrues interest at GBP LIBOR plus 0.975%, subject to adjustments based on our credit ratings. Concurrently, we entered into a three-year interest rate swap agreement that fixes the rate of the term loan at 1.79%, and a foreign currency swap agreement that fixes the British pound sterling (“GBP”) into U.S. dollars (“USD”) exchange rate at 1.5149 on interest income from the HC-One Facility in excess of interest payments on the term loan. Proceeds from this term loan repaid £220 million of the GBP balance drawn on our revolving credit facility that was used to fund our HC-One Facility in November 2014.

In May 2015, we issued $750 million of 4.00% senior unsecured notes due 2025. The notes were priced at 99.126% of the principal amount with a yield-to-maturity of 4.107%. Net proceeds were used to fund a portion of our investment transactions completed to date.

In June 2015, we established an at-the-market equity offering program (“ATM Program”), in connection with the renewal of our Shelf Registration Statement. Under this program, we may sell shares of our common stock from time to time having an aggregate gross sales price of up to $750 million through a consortium of banks acting as sales agents or directly to the banks acting as principals. During the three and nine months ended September 30, 2015, the Company issued 1.25 million shares of common stock at a weighted average price of $40.58 for proceeds of $50 million, net of fees and commissions of $1 million.

In July 2015, we sold a parcel of land at The Cove for $11 million; additionally, in October 2015, we sold a parcel of land in our life science segment for $40 million.

In October 2015, we issued a 49% noncontrolling interest in HCP Ventures V to an institutional capital investor for $110 million. HCP Ventures V owns the MOB portfolio we acquired through a sale-leaseback transaction with Memorial Hermann in June 2015. We retained a 51% controlling interest in HCP Ventures V and will act as the managing member of the joint venture.

Through November 3, 2015, we received £34 million ($52 million) and $23 million in loan paydowns from asset disposition proceeds relating to our HC-One Facility and loan to Delphis Operations, L.P., respectively.

### Dividends

On October 29, 2015, we announced that our Board declared a quarterly common stock cash dividend of $0.565 per share. The common stock dividend will be paid on November 24, 2015 to stockholders of record as of the close of business on November 9, 2015.

### Results of Operations

We evaluate our business and allocate resources among our business segments: (i) senior housing, (ii) post-acute/skilled nursing, (iii) life science, (iv) medical office and (v) hospital. Under the senior housing, post-acute/skilled nursing, life science and hospital segments, we primarily invest, through acquisition and development, in single operator or tenant properties and debt issued by operators in these sectors. Under the medical office segment, we invest, through acquisition and development, in single or multi-tenant MOBs, which generally require a greater level of property management.

### Non-GAAP Financial Measures

#### Net Operating Income (“NOI”)

NOI and adjusted NOI are non-GAAP supplemental financial measures used to evaluate the operating performance of real estate. NOI is defined as rental and related revenues, including tenant recoveries, resident fees and services, and income from direct financing leases (“DFLs”), less property level operating expenses; NOI excludes all other financial statement amounts included in net income (loss) as presented in Note 14 to the Consolidated Financial Statements. Management believes NOI provides relevant and useful information because it reflects only income and operating expense items that are incurred at the property level and presents them on an unleveraged basis. Adjusted NOI is calculated as NOI after eliminating the effects of straight-line rents, DFL accretion, amortization of market lease intangibles and lease termination fees. Adjusted NOI is oftentimes referred to as “cash NOI.” We use NOI and adjusted NOI to make decisions about resource allocations, to assess and compare property level performance, and evaluate our same property portfolio (“SPP”). We believe that net income (loss) is the most directly comparable U.S. generally accepted accounting principles (“GAAP”) measure to NOI. NOI should not be viewed as an alternative measure of operating performance to net income (loss) as defined by GAAP since it does not reflect various excluded items. Further, our definition of NOI may not be comparable to the definition used by other REITs or real estate companies, as they may use different methodologies for calculating NOI. NOI and adjusted NOI are non-GAAP supplemental financial measures; for a reconciliation of net income (loss) to NOI and adjusted NOI and other relevant disclosure, refer to Note 14 to the Consolidated Financial Statements.

Operating expenses generally relate to leased medical office and life science properties and senior housing RIDEA properties. We generally recover all or a portion of our leased medical office and life science property expenses through tenant recoveries. We present expenses as operating or general and administrative based on the underlying nature of the expense. Periodically, we review the classification of expenses between categories and make revisions based on changes in the underlying nature of the expenses.

#### Same Property Portfolio (“SPP”)

SPP NOI and adjusted NOI information allows us to evaluate the performance of our property portfolio under a consistent population by eliminating changes in the composition of our portfolio of properties. We identify our SPP as stabilized properties that remained in operations and were consistently reported as leased properties or RIDEA properties for the duration of the year over year comparison periods presented, excluding assets held for sale. Accordingly, it takes a stabilized property a minimum of 12 months in operations under a consistent reporting structure to be included in our SPP. Newly acquired operating assets are generally considered stabilized at the earlier of lease up (typically when the tenant(s) controls the physical use of at least 80% of the space) or 12 months from the acquisition date. Newly completed developments and redevelopments are considered stabilized at the earlier of lease up or 24 months from the date the property is placed in service. SPP NOI excludes certain non-property specific operating expenses that are allocated to each operating segment on a consolidated basis. SPP adjusted NOI excludes the effects of foreign exchange rate movements by using the average current period exchange rate to translate from GBP into USD for the comparison periods. A property is removed from our SPP when it is sold, placed into redevelopment or changes its reporting structure.

#### Funds From Operations (“FFO”)

We believe FFO applicable to common shares, diluted FFO applicable to common shares, and diluted FFO per common share are important supplemental non-GAAP measures of operating performance for a REIT. Because the historical cost accounting convention used for real estate assets utilizes straight-line depreciation (except on land), such accounting presentation implies that the value of real estate assets diminishes predictably over time. Since real estate values instead have historically risen and fallen with market conditions, presentations of operating results for a REIT that use historical cost accounting for depreciation could be less informative. The term FFO was designed by the REIT industry to address this issue.

FFO as defined by the National Association of Real Estate Investment Trusts (“NAREIT”) is net income (loss) applicable to common shares (computed in accordance with GAAP), excluding gains or losses from sales of property, impairments of, or related to, depreciable real estate, plus real estate and DFL depreciation and amortization, and after adjustments for joint ventures. Adjustments for joint ventures are calculated to reflect FFO on the same basis. FFO does not represent cash generated from operating activities in accordance with GAAP, is not necessarily indicative of cash available to fund cash needs and should not be considered an alternative to net income (loss). We compute FFO in accordance with the current NAREIT definition; however, other REITs may report FFO differently or have a different interpretation of the current NAREIT definition from ours.

In addition, we present FFO before the impact of severance-related charges, litigation settlement charges, preferred stock redemption charges, impairments (recoveries) of non-depreciable assets, foreign currency remeasurement losses (gains) and transaction-related items (defined below) (“FFO as adjusted”). Transaction-related items include acquisition and pursuit costs (e.g., due diligence and closing) and gains/charges incurred as a result of mergers and acquisitions and lease amendment or termination activities. Management believes that FFO as adjusted provides a meaningful supplemental measurement of our FFO run-rate. This measure is a modification of the NAREIT definition of FFO and should not be used as an alternative to net income (loss) (determined in accordance with GAAP) or NAREIT FFO. FFO and FFO as adjusted are non-GAAP supplemental financial measures; for a reconciliation of net income (loss) to FFO and FFO as adjusted and other relevant disclosure, refer to “Non-GAAP Financial Measures Reconciliations” below.

#### Funds Available for Distribution (“FAD”)

FAD is defined as FFO as adjusted after excluding the impact of the following: (i) amortization of acquired market lease intangibles, net; (ii) amortization of deferred compensation expense; (iii) amortization of deferred financing costs, net; (iv) straight-line rents; (v) accretion and depreciation related to DFLs and lease incentive amortization (reduction of straight-line rents); and (vi) deferred revenues, excluding amounts amortized into rental income that are associated with tenant funded improvements owned/recognized by us and up-front cash payments made by tenants to reduce their contractual rents. Also, FAD is: (i) computed after deducting recurring capital expenditures, including leasing costs and second generation tenant and capital improvements; and (ii) includes lease restructure payments and adjustments to compute our share of FAD from our unconsolidated joint ventures and those related to CCRC non-refundable entrance fees. Other REITs or real estate companies may use different methodologies for calculating FAD, and accordingly, our FAD may not be comparable to those reported by other REITs. Although our FAD computation may not be comparable to that of other REITs, management believes FAD provides a meaningful supplemental measure of our performance and is frequently used by analysts, investors, and other interested parties in the evaluation of our performance as a REIT. FAD does not represent cash generated from operating activities determined in accordance with GAAP, is not necessarily indicative of cash available to fund cash needs, and should not be considered as an alternative to net income (loss) determined in accordance with GAAP. FAD is a non-GAAP supplemental financial measure; for a reconciliation of net income (loss) to FAD, as defined, and other relevant disclosure, refer to “Non-GAAP Financial Measures Reconciliations” below.

### Comparison of the Three Months Ended September 30, 2015 to the Three Months Ended September 30, 2014

On June 30, 2015 (the “Closing Date”), we completed the RIDEA III acquisition for 35 senior housing properties (see Note 4 to the Consolidated Financial Statements). We report the resident level fees and services revenues and corresponding operating expenses in our consolidated financial statements from the Closing Date. For periods subsequent to the Closing Date, we expect increases in resident fees and services revenue and operating expenses.

#### Overview(1)

Results for the three months ended September 30, 2015 and 2014 follow (dollars in thousands except per share data):

|  | Three Months Ended September 30, 2015 Amount | Per Share | Three Months Ended September 30, 2014 Amount | Per Share | Per Share Change |
| --- | ---: | ---: | ---: | ---: | ---: |
| **FFO** | $263,370 | $0.57 | $377,304 | $0.82 | $(0.25) |
| **FFO as adjusted** | 365,800 | 0.79 | 346,278 | 0.75 | 0.04 |
| **FAD** | 309,946 | 0.67 | 297,709 | 0.65 | 0.02 |
| **Net income applicable to common shares** | 115,046 | 0.25 | 247,208 | 0.54 | (0.29) |

(1) For the reconciliations, see “Non-GAAP Financial Measures Reconciliations” section below.

FFO as adjusted and FAD increased $0.04 and $0.02 per share, respectively, primarily as a result of increased NOI from our 2014 and 2015 acquisitions and SPP. The increases were partially offset by the decline in income from DFLs as a result of the HCRMC Lease Amendment.

FFO and earnings per share (“EPS”) decreased $0.25 and $0.29 per share, respectively, primarily as a result of: (i) a $70 million impairment related to our investment in Four Seasons senior notes (“Four Seasons Notes”), (ii) a $27 million impairment related to our equity investment in HCRMC, (iii) foreign currency remeasurement losses of $4 million and (iv) transaction-related items of $2 million. The decreases were partially offset by: (i) the aforementioned events impacting FFO as adjusted and FAD and (ii) $38 million recognized in 2014 in net fees for terminating the leases on the 49 senior housing properties in the transaction completed with Brookdale in August 2014 (the “Brookdale Transaction”).

#### Segment NOI and Adjusted NOI

The tables below provide selected operating information for our SPP and total property portfolio for each of our business segments. Our consolidated SPP for the three months ended September 30, 2015 consists of 1,033 properties representing properties acquired or placed in service and stabilized on or prior to July 1, 2014 and that remained in operations under a consistent reporting structure through September 30, 2015. Our consolidated total property portfolio represents 1,184 and 1,103 properties at September 30, 2015 and 2014, respectively.

Results as of and for the three months ended September 30, 2015 and 2014 (dollars and square feet in thousands except per capacity data) follows:

### Senior Housing

|  | SPP Three Months Ended September 30, 2015 | 2014 | Change | Total Portfolio Three Months Ended September 30, 2015 | 2014 | Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Rental revenues(1) | $128,503 | $128,137 | $366 | $131,267 | $183,834 | $(52,567) |
| Resident fees and services | 40,304 | 38,419 | 1,885 | 155,290 | 62,213 | 93,077 |
| Total segment revenues | 168,807 | 166,556 | 2,251 | 286,557 | 246,047 | 40,510 |
| Operating expenses | (26,104) | (24,206) | (1,898) | (111,167) | (43,017) | (68,150) |
| NOI | 142,703 | 142,350 | 353 | 175,390 | 203,030 | (27,640) |
| Non-cash adjustments to NOI | (5,862) | (8,672) | 2,810 | (6,141) | (47,518) | 41,377 |
| Adjusted NOI | $136,841 | $133,678 | $3,163 | $169,249 | $155,512 | $13,737 |
| Adjusted NOI % change |  |  | 2.4% |  |  |  |
| Property count(2) | 402 | 402 |  | 508 | 463 |  |
| Average capacity (units)(3) | 38,867 | 39,142 |  | 50,498 | 44,202 |  |
| Average annual rent per unit(4) | $14,124 | $13,719 |  | $13,500 | $14,154 |  |

(1) Represents rental and related revenues and income from DFLs.

(2) From our past presentation of SPP for the three months ended September 30, 2014, we removed 10 senior housing properties from SPP that were sold and three senior housing properties that were contributed to partnerships under a RIDEA structure, and no longer meet our criteria for SPP as of the date of contribution.

(3) Represents average capacity as reported by the respective tenants or operators for the twelve-month period and a quarter in arrears from the periods presented.

(4) Average annual rent per unit for RIDEA properties is based on NOI.

*SPP Adjusted NOI.* SPP adjusted NOI improved primarily as a result of annual rent increases.

*Total Portfolio NOI.* Our total portfolio NOI decreased primarily as a result of: (i) $34 million related to terminating the leases on 49 senior housing properties and converting to a RIDEA structure in the Brookdale Transaction, (ii) contributing three assets into the CCRC JV in August 2014 and (iii) the sale of nine assets in January 2015 and May 2015 as part of the Brookdale Transaction (see Notes 3 and 5 to the Consolidated Financial Statements), partially offset by the impact from our senior housing acquisitions in 2014 and 2015, primarily from our RIDEA III transaction in June 2015 (see Note 4 to the Consolidated Financial Statements), and results from our SPP.

### Post-Acute/Skilled Nursing

|  | SPP Three Months Ended September 30, 2015 | 2014 | Change | Total Portfolio Three Months Ended September 30, 2015 | 2014 | Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Rental revenues(1) | $128,549 | $138,750 | $(10,201) | $132,650 | $139,205 | $(6,555) |
| Operating expenses | (76) | (73) | (3) | (531) | (534) | 3 |
| NOI | 128,473 | 138,677 | (10,204) | 132,119 | 138,671 | (6,552) |
| Non-cash adjustments to NOI | (19,865) | (16,639) | (3,226) | (20,362) | (16,693) | (3,669) |
| Adjusted NOI | $108,608 | $122,038 | $(13,430) | $111,757 | $121,978 | $(10,221) |
| Adjusted NOI % change |  |  | (11.0)% |  |  |  |
| Property count(2) | 300 | 300 |  | 321 | 301 |  |
| Average capacity (beds)(3) | 37,981 | 38,222 |  | 39,363 | 38,400 |  |
| Average annual rent per bed | $11,445 | $12,778 |  | $11,410 | $12,761 |  |

(1) Represents rental and related revenues and income from DFLs.

(2) From our past presentation of SPP for the three months ended September 30, 2014, we removed a post-acute/skilled nursing facility from SPP that was sold.

(3) Represents average capacity as reported by the respective tenants or operators for the twelve-month period and a quarter in arrears from the periods presented.

*NOI and Adjusted NOI.* SPP and total portfolio NOI and adjusted NOI decreased primarily as a result of the HCRMC Lease Amendment. See “2015 Transaction Overview” above for further discussion on developments with HCRMC, including the September 2015 impairment related to our equity investment in HCRMC.

### Life Science

|  | SPP Three Months Ended September 30, 2015 | 2014 | Change | Total Portfolio Three Months Ended September 30, 2015 | 2014 | Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Rental and related revenues | $67,799 | $64,357 | $3,442 | $71,304 | $66,273 | $5,031 |
| Tenant recoveries | 14,074 | 12,519 | 1,555 | 14,836 | 13,177 | 1,659 |
| Total segment revenues | 81,873 | 76,876 | 4,997 | 86,140 | 79,450 | 6,690 |
| Operating expenses | (15,749) | (14,592) | (1,157) | (17,785) | (16,637) | (1,148) |
| NOI | 66,124 | 62,284 | 3,840 | 68,355 | 62,813 | 5,542 |
| Non-cash adjustments to NOI | (2,339) | (1,961) | (378) | (2,613) | (2,091) | (522) |
| Adjusted NOI | $63,785 | $60,323 | $3,462 | $65,742 | $60,722 | $5,020 |
| Adjusted NOI % change |  |  | 5.7% |  |  |  |
| Property count(1) | 109 | 109 |  | 112 | 112 |  |
| Average occupancy | 97.6% | 93.6% |  | 97.7% | 93.7% |  |
| Average occupied square feet | 6,906 | 6,610 |  | 7,209 | 6,739 |  |
| Average annual total segment revenues per occupied square foot | $46 | $45 |  | $46 | $46 |  |
| Average annual base rent per occupied square foot | $38 | $38 |  | $38 | $38 |  |

(1) From our past presentation of SPP for the three months ended September 30, 2014, we removed a life science facility from SPP that was placed into land held for development, which no longer meets our criteria for SPP as of the date placed into development.

*SPP NOI and Adjusted NOI.* SPP NOI and adjusted NOI increased primarily as a result of increased occupancy. Additionally, SPP adjusted NOI increased as a result of annual rent escalations.

*Total Portfolio NOI and Adjusted NOI.* In addition to the impact of our SPP, our total portfolio NOI and adjusted NOI increased primarily as a result of the impact of our life science development projects placed into service during 2014.

During the three months ended September 30, 2015, 88,000 square feet of new and renewal leases commenced at an average annual base rent of $39.85 per square foot compared to 64,000 square feet of expired and terminated leases with an average annual base rent of $41.15 per square foot.

### Medical Office

|  | SPP Three Months Ended September 30, 2015 | 2014 | Change | Total Portfolio Three Months Ended September 30, 2015 | 2014 | Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Rental and related revenues | $77,058 | $74,135 | $2,923 | $92,275 | $76,876 | $15,399 |
| Tenant recoveries | 15,104 | 14,730 | 374 | 17,640 | 15,536 | 2,104 |
| Total segment revenues | 92,162 | 88,865 | 3,297 | 109,915 | 92,412 | 17,503 |
| Operating expenses | (36,195) | (35,614) | (581) | (43,432) | (38,459) | (4,973) |
| NOI | 55,967 | 53,251 | 2,716 | 66,483 | 53,953 | 12,530 |
| Non-cash adjustments to NOI | 132 | 584 | (452) | (1,363) | 528 | (1,891) |
| Adjusted NOI | $56,099 | $53,835 | $2,264 | $65,120 | $54,481 | $10,639 |
| Adjusted NOI % change |  |  | 4.2% |  |  |  |
| Property count(1) | 206 | 206 |  | 227 | 211 |  |
| Average occupancy | 90.3% | 90.9% |  | 91.3% | 90.7% |  |
| Average occupied square feet | 12,676 | 12,758 |  | 15,556 | 13,347 |  |
| Average annual total segment revenues per occupied square foot | $29 | $28 |  | $28 | $28 |  |
| Average annual base rent per occupied square foot | $24 | $23 |  | $23 | $23 |  |

(1) From our past presentation of SPP for the three months ended September 30, 2014, we removed a MOB from SPP that was sold.

*SPP NOI and Adjusted NOI.* SPP NOI and adjusted NOI increased as a result of annual rent escalations.

*Total Portfolio NOI and Adjusted NOI.* Our total portfolio NOI and adjusted NOI increased primarily as a result of the impact of our MOB acquisitions in the second half of 2014 and 2015.

During the three months ended September 30, 2015, 572,000 square feet of new and renewal leases commenced at an average annual base rent of $23.87 per square foot compared to 517,000 square feet of expiring and terminated leases with an average annual base rent of $23.40 per square foot. During the three months ended September 30, 2015, we disposed of 17,000 square feet with an average annual base rent of $17.50 per square foot.

### Hospital

|  | SPP Three Months Ended September 30, 2015 | 2014 | Change | Total Portfolio Three Months Ended September 30, 2015 | 2014 | Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Rental revenues(1) | $21,773 | $20,937 | $836 | $21,787 | $20,950 | $837 |
| Tenant recoveries | 609 | 610 | (1) | 608 | 610 | (2) |
| Total segment revenues | 22,382 | 21,547 | 835 | 22,395 | 21,560 | 835 |
| Operating expenses | (601) | (950) | 349 | (600) | (952) | 352 |
| NOI | 21,781 | 20,597 | 1,184 | 21,795 | 20,608 | 1,187 |
| Non-cash adjustments to NOI | 288 | 130 | 158 | 286 | 130 | 156 |
| Adjusted NOI | $22,069 | $20,727 | $1,342 | $22,081 | $20,738 | $1,343 |
| Adjusted NOI % change |  |  | 6.5% |  |  |  |
| Property count | 16 | 16 |  | 16 | 16 |  |
| Average capacity (beds)(2) | 2,223 | 2,221 |  | 2,223 | 2,221 |  |
| Average annual rent per bed | $40,797 | $39,040 |  | $40,816 | $39,063 |  |

(1) Represents rental and related revenues and income from DFLs.

(2) Represents capacity as reported by the respective tenants or operators for the twelve-month period and a quarter in arrears from the periods presented. Certain operators in our hospital portfolio are not required under their respective leases to provide operational data.

*NOI and Adjusted NOI.* SPP and total portfolio NOI and adjusted NOI increased primarily as a result of the recovery of rents and operating expenses from the first half of 2015 from one of our hospitals.

### Other Income and Expense Items

#### Interest income

Interest income increased $2 million to $20 million for the three months ended September 30, 2015. The increase was primarily the result of: (i) our HC-One Facility funded in November 2014 and February 2015 (see Note 7 to the Consolidated Financial Statements), (ii) additional fundings under our mezzanine loan facility with Tandem in May 2015 (see Note 7 to the Consolidated Financial Statements), offset by a change in interest income recognition on our investment in the Four Seasons Notes (see Note 15 to the Consolidated Financial Statements).

#### Interest expense

Interest expense increased $11 million to $122 million for the three months ended September 30, 2015. The increase was primarily the result of: (i) our senior unsecured notes offerings during 2014 and 2015, (ii) increased borrowings under our line of credit facility and (iii) increased borrowings from our term loan originated in 2015. The increases in interest expense were partially offset by repayments of senior unsecured notes and mortgage debt that matured during 2014 and 2015. The increased borrowings were used to fund our investment activities and to refinance our debt maturities.

Our exposure to expense fluctuations related to our variable rate indebtedness is substantially mitigated by our interest rate swap contracts. For a more detailed discussion of our interest rate risk, see “Quantitative and Qualitative Disclosures About Market Risk” in Item 3.

The table below sets forth information with respect to our debt, excluding premiums and discounts (dollars in thousands):

| Balance: | As of September 30, (1) 2015 | 2014 |
| --- | ---: | ---: |
| Fixed rate | $10,081,236 | $9,066,872 |
| Variable rate | 1,000,824 | 78,500 |
| Total | $11,082,060 | $9,145,372 |
| **Percent of total debt:** |  |  |
| Fixed rate | 91.0% | 99.1% |
| Variable rate | 9.0% | 0.9% |
| Total | 100.0% | 100.0% |
| **Weighted average interest rate at end of period:** |  |  |
| Fixed rate | 4.70% | 5.05% |
| Variable rate | 1.52% | 1.26% |
| Total | 4.41% | 5.01% |

(1) At September 30, 2015, excludes $95 million of other debt that represents non-interest bearing life care bonds and occupancy fee deposits at certain of our senior housing facilities and demand notes that have no scheduled maturities. At September 30, 2014, excludes $98 million of other debt that represents non-interest bearing life care bonds and occupancy fee deposits at certain of our senior housing facilities. At September 30, 2015 and 2014, $71 million and $72 million, respectively, of variable-rate mortgages and £357 million and £137 million ($541 million and $222 million), respectively, of term loans are presented as fixed-rate debt as the interest payments were swapped from variable to fixed (see Note 21 to the Consolidated Financial Statements).

#### Depreciation and amortization expense

Depreciation and amortization expense increased $12 million to $135 million for the three months ended September 30, 2015. The increase was primarily the result of the impact of our acquisitions and redevelopment projects placed in service during 2014 and 2015. The increases in depreciation and amortization expense were partially offset by additional depreciation expense recognized in the third quarter of 2014 as a result of a change in estimate of the depreciable life and residual value of certain properties.

#### General and administrative expenses

General and administrative expenses increased $1 million to $21 million for the three months ended September 30, 2015. The increase was primarily the result of higher compensation related expenses.

#### Acquisition and pursuit costs

Acquisition and pursuit costs decreased $4 million to $2 million for the three months ended September 30, 2015. The decrease was primarily due to lower levels of transactional activity in 2015 compared to the same period in 2014 as a result of the Brookdale Transaction. Acquisition and pursuit costs were previously included in general and administrative expenses.

#### Impairments

During the three months ended September 30, 2015, we recognized an impairment charge of $70 million related to our investment in Four Seasons Notes (see Note 15 to the Consolidated Financial Statements).

#### Other (expense) income, net

Other (expense) income, net decreased $4 million to an expense of $1 million for the three months ended September 30, 2015. The decrease was primarily the result of the impact from remeasuring assets and liabilities denominated in GBP to USD.

#### Income tax benefit (expense)

Income taxes decreased $2 million to a benefit of $2 million for the three months ended September 30, 2015. The decrease was primarily the result of the tax benefit related to our share of losses from our RIDEA joint ventures formed as part of the Brookdale Transaction and related to our U.K. real estate investments in 2015.

#### Equity income from unconsolidated joint ventures

Equity income from unconsolidated joint ventures decreased $2 million to $8 million for the three months ended September 30, 2015. The decrease was primarily the result of our share of losses recognized from the CCRC JV.

#### Impairment of investments in unconsolidated joint ventures

During the three months ended September 30, 2015, we recognized an impairment charge of $27 million related to our equity investment in HCRMC (see Note 15 to the Consolidated Financial Statements).

### Comparison of the nine months ended September 30, 2015 to the nine months ended September 30, 2014

#### Overview(1)

Results for the nine months ended September 30, 2015 and 2014 follow (dollars in thousands except per share data):

|  | Nine Months Ended September 30, 2015 Amount | Per Share | Nine Months Ended September 30, 2014 Amount | Per Share | Per Share Change |
| --- | ---: | ---: | ---: | ---: | ---: |
| **FFO** | $447,838 | $0.97 | $1,056,888 | $2.30 | $(1.33) |
| **FFO as adjusted** | 1,095,234 | 2.36 | 1,033,763 | 2.25 | 0.11 |
| **FAD** | 948,257 | 2.05 | 873,855 | 1.90 | 0.15 |
| **Net income applicable to common shares** | 38,613 | 0.08 | 723,651 | 1.58 | (1.50) |

(1) For the reconciliations, see “Non-GAAP Financial Measures Reconciliations” section below.

FFO as adjusted and FAD increased $0.11 and $0.15 per share, respectively, primarily as a result of increased NOI from our 2014 and 2015 acquisitions and SPP, and incremental interest income from the repayments of two development loans resulting from our share in the appreciation of the underlying real estate assets. The increases were partially offset by the decline in income from DFLs as a result of the HCRMC Lease Amendment.

FFO and EPS decreased $1.33 and $1.50 per share, respectively, primarily as a result of: (i) a $478 million impairment related to our DFL investments with HCRMC, (ii) $112 million of impairments related to our investment in Four Seasons Notes, (iii) transaction-related items of $29 million, (iv) a $27 million impairment related to our equity investment in

HCRMC and (v) a severance-related charge of $7 million. The decreases were partially offset by: (i) the aforementioned events impacting FFO as adjusted and FAD (ii) $38 million recognized in 2014 in net fees for terminating the leases on the 49 senior housing properties in the Brookdale Transaction and (iii) foreign currency remeasurement gains of $5 million.

#### Segment NOI and Adjusted NOI

The tables below provide selected operating information for our SPP and total property portfolio for each of our business segments. Our consolidated SPP for the nine months ended September 30, 2015 consists of 1,007 properties representing properties acquired or placed in service and stabilized on or prior to January 1, 2014 and that remained in operations under a consistent reporting structure through September 30, 2015.

Results as of and for the nine months ended September 30, 2015 and 2014 (dollars and square feet in thousands except per capacity data) follows:

### Senior Housing

|  | SPP Nine Months Ended September 30, 2015 | 2014 | Change | Total Portfolio Nine Months Ended September 30, 2015 | 2014 | Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Rental revenues(1) | $374,178 | $372,620 | $1,558 | $382,559 | $485,823 | $(103,264) |
| Resident fees and services | 119,373 | 114,398 | 4,975 | 367,141 | 138,205 | 228,936 |
| Total segment revenues | 493,551 | 487,018 | 6,533 | 749,700 | 624,028 | 125,672 |
| Operating expenses | (75,359) | (72,538) | (2,821) | (263,191) | (92,388) | (170,803) |
| NOI | 418,192 | 414,480 | 3,712 | 486,509 | 531,640 | (45,131) |
| Non-cash adjustments to NOI | (19,056) | (29,862) | 10,806 | (11,316) | (72,277) | 60,961 |
| Adjusted NOI | $399,136 | $384,618 | $14,518 | $475,193 | $459,363 | $15,830 |
| Adjusted NOI % change |  |  | 3.8% |  |  |  |
| Property count(2) | 380 | 380 |  | 508 | 463 |  |
| Average capacity (units)(3) | 37,839 | 38,113 |  | 46,729 | 45,123 |  |
| Average annual rent per unit(4) | $14,106 | $13,497 |  | $13,654 | $13,654 |  |

(1) Represents rental and related revenues and income from DFLs.

(2) From our past presentation of SPP for the nine months ended September 30, 2014, we removed nine senior housing properties from SPP that were sold and three senior housing properties that were contributed to partnerships under a RIDEA structure, and no longer meet our criteria for SPP as of the date of contribution.

(3) Represents average capacity as reported by the respective tenants or operators for the twelve-month period and a quarter in arrears from the periods presented.

(4) Average annual rent per unit for RIDEA properties is based on NOI.

*SPP Adjusted NOI*. SPP adjusted NOI improved as a result of annual rent increases and improved performance from RIDEA properties.

*Total Portfolio NOI.* Our total portfolio NOI decreased primarily as a result of: (i) $23 million related to terminating the leases on 49 senior housing properties and converting to a RIDEA structure in the Brookdale Transaction, (ii) an $8 million net termination fee related to our RIDEA III acquisition (see Note 4 to the Consolidated Financial Statements), (iii) contributing three assets into the CCRC JV in August 2014 and (iv) the sale of nine assets in January 2015 and May 2015 as part of the Brookdale Transaction (see Notes 3 and 5 to the Consolidated Financial Statements). The decreases in NOI were partially offset by the impact from our SPP and senior housing acquisitions in 2014 and 2015 primarily from our RIDEA III transaction in June 2015 (see Note 4 to the Consolidated Financial Statements).

### Post-Acute/Skilled Nursing

|  | SPP Nine Months Ended September 30, 2015 | 2014 | Change | Total Portfolio Nine Months Ended September 30, 2015 | 2014 | Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Rental revenues(1) | $395,435 | $413,204 | $(17,769) | $404,121 | $415,533 | $(11,412) |
| Operating expenses | (230) | (214) | (16) | (1,602) | (1,599) | (3) |
| NOI | 395,205 | 412,990 | (17,785) | 402,519 | 413,934 | (11,415) |
| Non-cash adjustments to NOI | (56,493) | (51,516) | (4,977) | (57,522) | (51,752) | (5,770) |
| Adjusted NOI | $338,712 | $361,474 | $(22,762) | $344,997 | $362,182 | $(17,185) |
| Adjusted NOI % change |  |  | (6.3)% |  |  |  |
| Property count(2) | 300 | 300 |  | 321 | 301 |  |
| Average capacity (beds)(3) | 37,981 | 38,222 |  | 38,904 | 38,481 |  |
| Average annual rent per bed | $11,897 | $12,616 |  | $11,877 | $12,603 |  |

(1) Represents rental and related revenues and income from DFLs.

(2) From our past presentation of SPP for the nine months ended September 30, 2014, we removed a post-acute/skilled nursing facility from SPP that was sold.

(3) Represents average capacity as reported by the respective tenants or operators for the twelve-month period and a quarter in arrears from the periods presented.

*NOI and Adjusted NOI.* SPP and total portfolio NOI and adjusted NOI decreased primarily as a result of the HCRMC Lease Amendment. See 2015 Transaction Overview” above for further discussion of developments with HCRMC, including the September 2015 impairment related to our equity investment in HCRMC.

### Life Science

|  | SPP Nine Months Ended September 30, 2015 | 2014 | Change | Total Portfolio Nine Months Ended September 30, 2015 | 2014 | Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Rental and related revenues | $197,231 | $188,660 | $8,571 | $211,411 | $196,384 | $15,027 |
| Tenant recoveries | 39,679 | 34,631 | 5,048 | 43,689 | 36,729 | 6,960 |
| Total segment revenues | 236,910 | 223,291 | 13,619 | 255,100 | 233,113 | 21,987 |
| Operating expenses | (43,562) | (40,240) | (3,322) | (51,718) | (46,247) | (5,471) |
| NOI | 193,348 | 183,051 | 10,297 | 203,382 | 186,866 | 16,516 |
| Non-cash adjustments to NOI | (7,244) | (7,344) | 100 | (8,433) | (7,976) | (457) |
| Adjusted NOI | $186,104 | $175,707 | $10,397 | $194,949 | $178,890 | $16,059 |
| Adjusted NOI % change |  |  | 5.9% |  |  |  |
| Property count(1) | 107 | 107 |  | 112 | 112 |  |
| Average occupancy | 96.9% | 92.2% |  | 96.8% | 92.4% |  |
| Average occupied square feet | 6,710 | 6,379 |  | 7,141 | 6,572 |  |
| Average annual total revenues per occupied square foot(1) | $46 | $45 |  | $46 | $46 |  |
| Average annual base rent per occupied square foot | $38 | $38 |  | $38 | $38 |  |

(1) From our past presentation of SPP for the nine months ended September 30, 2014, we removed a life science facility from SPP that was placed into land held for development, which no longer meets our criteria for SPP as of the date placed into development.

*SPP NOI and Adjusted NOI.* SPP NOI and adjusted NOI increased primarily as a result of increased occupancy. Additionally, SPP adjusted NOI increased as a result of annual rent escalations.

*Total Portfolio NOI and Adjusted NOI.* In addition to the impact of our SPP, our total portfolio NOI and adjusted NOI increased primarily as a result of the impact of our life science development projects placed into service during 2014 and a life science acquisition in 2014.

During the nine months ended September 30, 2015, 628,000 square feet of new and renewal leases commenced at an average annual base rent of $34.22 per square foot compared to 357,000 square feet of expired and terminated leases with an average annual base rent of $35.61 per square foot.

### Medical Office

|  | SPP Nine Months Ended September 30, 2015 | 2014 | Change | Total Portfolio Nine Months Ended September 30, 2015 | 2014 | Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Rental and related revenues | $226,579 | $222,661 | $3,918 | $262,047 | $229,880 | $32,167 |
| Tenant recoveries | 42,568 | 41,914 | 654 | 48,758 | 43,335 | 5,423 |
| Total revenues | 269,147 | 264,575 | 4,572 | 310,805 | 273,215 | 37,590 |
| Operating expenses | (103,960) | (102,675) | (1,285) | (122,469) | (111,140) | (11,329) |
| NOI | 165,187 | 161,900 | 3,287 | 188,336 | 162,075 | 26,261 |
| Non-cash adjustments to NOI | (1,040) | (704) | (336) | (4,399) | (795) | (3,604) |
| Adjusted NOI | $164,147 | $161,196 | $2,951 | $183,937 | $161,280 | $22,657 |
| Adjusted NOI % change |  |  | 1.8% |  |  |  |
| Property count(1) | 204 | 204 |  | 227 | 211 |  |
| Average occupancy | 90.4% | 91.2% |  | 90.8% | 90.8% |  |
| Average occupied square feet | 12,548 | 12,665 |  | 14,502 | 13,046 |  |
| Average annual total revenues per occupied square foot | $28 | $28 |  | $28 | $28 |  |
| Average annual base rent per occupied square foot | $24 | $23 |  | $24 | $23 |  |

(1) From our past presentation of SPP for the nine months ended September 30, 2014, we removed a MOB from SPP that was sold.

*SPP NOI and Adjusted NOI.* SPP NOI and adjusted NOI increased as a result of annual rent escalations.

*Total Portfolio NOI and Adjusted NOI.* Our total portfolio NOI and adjusted NOI increased primarily as a result of the impact of our MOB acquisitions in 2014 and 2015.

During the nine months ended September 30, 2015, 1.7 million square feet of new and renewal leases commenced at an average annual base rent of $24.42 per square foot compared to 1.8 million square feet of expiring and terminated leases with an average annual base rent of $24.54 per square foot. During the nine months ended September 30, 2015, we acquired 1.9 million square feet with an average annual base rent of $16.02 per square foot, including 1.2 million square feet with a triple net annual base rent of $10.74 per square foot, and disposed of 17,000 square feet with an average annual base rent of $17.50 per square foot.

### Hospital

|  | SPP Nine Months Ended September 30, 2015 | 2014 | Change | Total Portfolio Nine Months Ended September 30, 2015 | 2014 | Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Rental revenues(1) | $64,182 | $62,532 | $1,650 | $64,220 | $62,569 | $1,651 |
| Tenant recoveries | 1,909 | 1,802 | 107 | 1,909 | 1,803 | 106 |
| Total segment revenues | 66,091 | 64,334 | 1,757 | 66,129 | 64,372 | 1,757 |
| Operating expenses | (2,908) | (2,792) | (116) | (2,908) | (2,799) | (109) |
| NOI | 63,183 | 61,542 | 1,641 | 63,221 | 61,573 | 1,648 |
| Non-cash adjustments to NOI | 764 | 302 | 462 | 764 | 301 | 463 |
| Adjusted NOI | $63,947 | $61,844 | $2,103 | $63,985 | $61,874 | $2,111 |
| Adjusted NOI % change |  |  | 3.4% |  |  |  |
| Property count | 16 | 16 |  | 16 | 16 |  |
| Average capacity (beds)(2) | 2,223 | 2,221 |  | 2,223 | 2,221 |  |
| Average annual rent per bed | $40,104 | $38,803 |  | $40,127 | $38,825 |  |

(1) Represents rental and related revenues and income from DFLs.

(2) Represents capacity as reported by the respective tenants or operators for the twelve-month period and a quarter in arrears from the periods presented. Certain operators in our hospital portfolio are not required under their respective leases to provide operational data.

*NOI and Adjusted NOI.* SPP and total portfolio NOI and adjusted NOI increased primarily as a result of additional rents earned in 2015 due to exceeding pre-established thresholds and annual rent escalations, partially offset by increased operating expenses.

### Other Income and Expense Items

#### Interest income

Interest income increased $38 million to $89 million for the nine months ended September 30, 2015. The increase was primarily the result of: (i) fundings through our HC-One Facility in November 2014 and February 2015 (see Note 7 to the Consolidated Financial Statements), (ii) incremental interest income from the repayments of two development loans resulting from the appreciation of the underlying real estate assets and (iii) additional fundings under our mezzanine loan facility with Tandem in May 2015 (see Note 7 to the Consolidated Financial Statements). The increases in interest income were partially offset by a change in interest income recognition on our investment in the Four Seasons Notes (see Note 15 to the Consolidated Financial Statements).

#### Interest expense

Interest expense increased $33 million to $358 million for the nine months ended September 30, 2015. The increase was primarily the result of: (i) our senior unsecured notes offerings during 2014 and 2015, (ii) increased borrowings from our term loan originated in 2015, (iii) increased borrowings under our line of credit facility and (iv) lower capitalized interest. The increases in interest expense were partially offset by repayments of senior unsecured notes and mortgage debt that matured during 2014 and 2015. The increased borrowings were used to fund our investment activities and to refinance our debt maturities.

Our exposure to expense fluctuations related to our variable rate indebtedness is substantially mitigated by our interest rate swap contracts. For a more detailed discussion of our interest rate risk, see “Quantitative and Qualitative Disclosures About Market Risk” in Item 3 below.

#### Depreciation and amortization expense

Depreciation and amortization expense increased $26 million to $370 million for the nine months ended September 30, 2015. The increase was primarily the result of the impact of our acquisitions and redevelopment projects placed in service during 2014 and 2015. The increases in depreciation and amortization expense were partially offset by additional depreciation expense recognized in 2014 as a result of a change in estimate of the depreciable life and residual value of certain properties.

#### General and administrative expenses

General and administrative expenses increased $12 million to $74 million for the nine months ended September 30, 2015. The increase was primarily the result of a $7 million severance-related charge resulting from the resignation of our former Executive Vice President and Chief Investment Officer in June 2015. In addition, the increase was the result of higher compensation related expenses.

#### Acquisition and pursuit costs

Acquisition and pursuit costs increased $10 million to $23 million for the nine months ended September 30, 2015. The increase was primarily due to higher levels of transactional activity in 2015. Acquisition and pursuit costs were previously included in general and administrative expenses.

#### Impairments

During the nine months ended September 30, 2015, we recognized the following impairment charges: (i) $478 million related to our DFL investments with HCRMC, (ii) $112 million related to our investment in Four Seasons Notes and (iii) $3 million related to a MOB. See Notes 6 and 15 to the Consolidated Financial Statements.

#### Other (expense) income, net

Other (expense) income, net increased $6 million to $12 million for the nine months ended September 30, 2015. The increase was primarily the result of the impact from remeasuring assets and liabilities denominated in GBP to USD.

#### Income tax benefit (expense)

Income taxes decreased $9 million to a benefit of $7 million for the nine months ended September 30, 2015. The decrease was primarily the result of the tax benefit related to our share of operating losses from our RIDEA joint ventures formed as part of the Brookdale Transaction and related to our U.K. real estate investments in 2015.

#### Equity income from unconsolidated joint ventures

Equity income from unconsolidated joint ventures decreased $5 million to $34 million for the nine months ended September 30, 2015. The decrease was primarily the result of our share of losses recognized from the CCRC JV.

#### Impairment of investments in unconsolidated joint ventures

During the nine months ended September 30, 2015, we recognized an impairment charge of $27 million related to our equity investment in HCRMC (see Note 15 to the Consolidated Financial Statements).

#### Gain on sales of real estate

During the nine months ended September 30, 2015, we sold nine senior housing facilities and a MOB and recognized gains of $6 million. During the nine months ended September 30, 2014, we sold two post-acute/skilled nursing facilities, a hospital and a MOB, recognizing gains of $28 million.

### Liquidity and Capital Resources

We anticipate: (i) funding recurring operating expenses, (ii) meeting debt service requirements including principal payments and maturities, and (iii) satisfying our distributions to our stockholders and non-controlling interest members, for the next 12 months primarily by using cash flow from operations, available cash balances and cash from our various financing activities.

Our principal investing needs for the next 12 months are to:

- fund capital expenditures, including tenant improvements and leasing costs; and
- fund future acquisition, transactional and development activities.

We anticipate satisfying these future investing needs using one or more of the following:

- issuance of common or preferred stock;
- issuance of additional debt, including unsecured notes and mortgage debt;
- draws on our credit facilities; and/or
- sale or exchange of ownership interests in properties.

Access to capital markets impacts our cost of capital and ability to refinance maturing indebtedness, as well as our ability to fund future acquisitions and development through the issuance of additional securities or secured debt. Credit ratings impact our ability to access capital and directly impact our cost of capital as well. For example, as noted below, our revolving line of credit facility accrues interest at a rate per annum equal to LIBOR plus a margin that depends upon our credit ratings. We also pay a facility fee on the entire revolving commitment that depends upon our credit ratings. As of October 30, 2015, we had a credit rating of BBB+ from Fitch, Baa1 from Moody’s and BBB+ from S&P on our senior unsecured debt securities.

### Cash Flow Summary

The following summary discussion of our cash flows is based on the consolidated statements of cash flows and is not meant to be an all-inclusive discussion of the changes in our cash flows for the periods presented below.

Cash and cash equivalents were $120 million and $184 million at September 30, 2015 and December 31, 2014, respectively, representing a decrease of $64 million. The following table sets forth changes in cash flows (in thousands):

|  | Nine Months Ended September 30, 2015 | 2014 | Change |
| --- | ---: | ---: | ---: |
| Net cash provided by operating activities | $867,660 | $883,022 | $(15,362) |
| Net cash used in investing activities | (1,685,585) | (957,225) | (728,360) |
| Net cash provided by (used in) financing activities | 755,880 | (142,825) | 898,705 |

The decrease in operating cash flow is the result of a net paydown of working capital. Our cash flow from operations is dependent upon the occupancy levels of our buildings, rental rates on leases, our tenants’ performance on their lease obligations, the level of operating expenses and other factors.

The following are significant investing and financing activities for the nine months ended September 30, 2015:

- made investments of $1.8 billion (development and acquisition of real estate, and investments in unconsolidated joint ventures and loans);
- paid dividends on common stock of $784 million, which were generally funded by cash provided by our operating activities and cash on hand; and
- raised proceeds of $2.0 billion primarily from issuances of senior unsecured notes, the term loan originated in January 2015, our net borrowings under our bank line of credit, and issuances of common stock; and repaid $450 million of senior unsecured notes and mortgage debt.

### Debt

#### Bank Line of Credit and Term Loan

Our $2.0 billion unsecured revolving line of credit facility (the “Facility”) matures on March 31, 2018 and contains a one-year extension option. Borrowings under the Facility accrue interest at LIBOR plus a margin that depends upon our credit ratings. We pay a facility fee on the entire revolving commitment that depends on our credit ratings. Based on our credit ratings at October 30, 2015, the margin on the Facility was 0.925%, and the facility fee was 0.15%. The Facility also includes a feature that will allow us to increase the borrowing capacity by an aggregate amount of up to $500 million, subject to securing additional commitments from existing lenders or new lending institutions. At September 30, 2015, we had $1.0 billion, including £242 million ($366 million), outstanding under the Facility with a weighted average effective interest rate of 1.52%.

On January 12, 2015, we entered into a credit agreement with a syndicate of banks for a £220 million ($333 million at September 30, 2015) four-year unsecured term loan (the “2015 Term Loan”) that accrues interest at a rate of GBP LIBOR plus 0.975%, subject to adjustments based on our credit ratings. Proceeds from this term loan were used to repay a £220 million draw on the Facility that partially funded the November 2014 HC-One Facility (see Note 7 to the Consolidated Financial Statements). Concurrently, we entered into a three-year interest rate swap agreement that effectively fixes the interest rate of the 2015 Term Loan at 1.79% (see Note 21 to the Consolidated Financial Statements). The 2015 Term Loan contains a one-year committed extension option.

The Facility and term loans contain certain financial restrictions and other customary requirements, including cross-default provisions to other indebtedness. Among other things, these covenants, using terms defined in the agreements, (i) limit the ratio of Consolidated Total Indebtedness to Consolidated Total Asset Value to 60%, (ii) limit the ratio of Secured Debt to Consolidated Total Asset Value to 30%, (iii) limit the ratio of Unsecured Debt to Consolidated Unencumbered Asset Value to 60% and (iv) require a minimum Fixed Charge Coverage ratio of 1.5 times. The Facility and term loans also require a Minimum Consolidated Tangible Net Worth of $9.5 billion at September 30, 2015. At September 30, 2015, we were in compliance with each of these restrictions and requirements.

#### Senior Unsecured Notes

At September 30, 2015, we had senior unsecured notes outstanding with an aggregate principal balance of $8.6 billion. Interest rates on the notes ranged from 2.79% to 6.88% with a weighted average effective interest rate of 4.71% and a weighted average maturity of six years at September 30, 2015. The senior unsecured notes contain certain covenants including limitations on debt, maintenance of unencumbered assets, cross-acceleration provisions and other customary terms. We believe we were in compliance with these covenants at September 30, 2015.

#### Mortgage Debt

At September 30, 2015, we had $940 million in aggregate principal amount of mortgage debt outstanding, which is secured by 63 healthcare facilities (including redevelopment properties) with a carrying value of $1.2 billion. At September 30, 2015, interest rates on the mortgage debt ranged from 3.16% to 8.35% with a weighted average effective interest rate of 6.21% and a weighted average maturity of three years.

Mortgage debt generally requires monthly principal and interest payments, is collateralized by real estate assets and is generally non-recourse. Mortgage debt typically restricts transfer of the encumbered assets, prohibits additional liens, restricts prepayment, requires payment of real estate taxes, requires maintenance of the assets in good condition, requires maintenance of insurance on the assets, and includes conditions to obtain lender consent to enter into and terminate material leases. Some of the mortgage debt is also cross-collateralized by multiple assets and may require tenants or operators to maintain compliance with the applicable leases or operating agreements of such real estate assets.

### Equity

At September 30, 2015, we had 464 million shares of common stock outstanding. At September 30, 2015, equity totaled $10.5 billion and our equity securities had a market value of $17.5 billion.

At September 30, 2015, non-managing members held an aggregate of 4 million units in five limited liability companies (“DownREITs”) for which we are the managing member. The DownREIT units are exchangeable for an amount of cash approximating the then-current market value of shares of our common stock or, at our option, shares of our common stock (subject to certain adjustments, such as stock splits and reclassifications).

#### At-The-Market Program

In June 2015, we established an ATM Program, in connection with the renewal of our Shelf Registration Statement. Under this program, we may sell shares of our common stock from time to time having an aggregate gross sales price of up to $750 million through a consortium of banks acting as sales agents or directly to the banks acting as principals. During the three and nine months ended September 30, 2015, we issued 1.25 million shares of common stock at a weighted average price of $40.58 for proceeds of $50 million, net of fees and commissions of $1 million. During October 2015, we issued 589,000 shares of common stock at a weighted average price of $39.20 for proceeds of $23 million, net of fees and commissions of $350,000. Actual future sales will depend upon a variety of factors, including but not limited to market conditions, the trading price of our common stock and our capital needs. We have no obligation to sell the remaining shares available for sale under our program.

#### Shelf Registration

We filed a prospectus with the U.S. Securities and Exchange Commission (the “SEC”) as part of a registration statement on Form S-3ASR, using a shelf registration process, which expires in June 2018. Under the “shelf” process, we may sell any combination of the securities described in the prospectus through one or more offerings. The securities described in the prospectus include common stock, preferred stock, depositary shares, debt securities and warrants.

#### Capital Market Outlook

The capital markets have facilitated our continued growth, including our international expansion. For the 21 months ended September 30, 2015, we have raised $2.5 billion in senior unsecured notes, originated a £220 million ($333 million) four-year unsecured term loan and increased our Facility from $1.5 billion to $2.0 billion. The capital raised, in combination with available cash and borrowing capacity under our Facility, supported $2.1 billion and $1.9 billion of investments completed during the year ended December 31, 2014 and nine months ended September 30, 2015, respectively. We believe our equity and debt investors, as well as our banking relationships, will provide additional capital as we pursue new investment opportunities.

### Contractual Obligations

The following table summarizes our material contractual payment obligations and commitments at September 30, 2015 (in thousands):

|  | Total(1) | 2015 (Three months) | 2016-2017 | 2018-2019 | More than Five Years |
| --- | ---: | ---: | ---: | ---: | ---: |
| Bank line of credit(2) | $1,000,824 | $— | $— | $1,000,824 | $— |
| Term loans(3) | 540,784 | — | 207,528 | 333,256 | — |
| Senior unsecured notes | 8,600,000 | — | 1,650,000 | 1,050,000 | 5,900,000 |
| Mortgage debt | 940,452 | 7,542 | 861,085 | 8,655 | 63,170 |
| Construction loan commitments(4) | 62,634 | 18,704 | 43,930 | — | — |
| Development commitments(5) | 94,384 | 48,370 | 46,014 | — | — |
| Ground and other operating leases | 385,887 | 2,155 | 14,750 | 13,972 | 355,010 |
| HCP Ventures IV support commitment | 110,790 | 57,790 | 53,000 | — | — |
| Interest(6) | 2,686,146 | 61,067 | 832,257 | 553,628 | 1,239,194 |
| Total | $14,421,901 | $195,628 | $3,708,564 | $2,960,335 | $7,557,374 |

(1) Excludes $95 million of other debt that represents Life Care Bonds and Demand Notes that have no scheduled maturities.

(2) Includes £242 million ($366 million) translated to USD.

(3) Represents £357 million translated to USD.

(4) Represents commitments to finance development projects, related working capital and capital expenditures. Includes £40 million ($60 million) translated to USD.

(5) Represents construction and other commitments for developments in progress.

(6) Interest on variable-rate debt is calculated using rates in effect at September 30, 2015.

### Off-Balance Sheet Arrangements

We own interests in certain unconsolidated joint ventures as described under Note 8 to the Consolidated Financial Statements. Except in limited circumstances, our risk of loss is limited to our investment in the joint venture and any outstanding loans receivable (see Note 18 to the Consolidated Financial Statements). In addition, we have certain properties which serve as collateral for debt that is owed by a previous owner of certain of our facilities. Our risk of loss for these certain properties is limited to the outstanding debt balance plus penalties, if any. We have no other material off-balance sheet arrangements that we expect would materially affect our liquidity and capital resources except those described above under “Contractual Obligations.”

### Inflation

Our leases often provide for either fixed increases in base rents or indexed escalators, based on the Consumer Price Index or other measures, and/or additional rent based on increases in the tenants’ operating revenues. Most of our MOB leases require the tenant to pay a share of property operating costs such as real estate taxes, insurance and utilities. Substantially all of our senior housing, life science, post-acute/skilled nursing and hospital leases require the operator or tenant to pay all of the property operating costs or reimburse us for all such costs. We believe that inflationary increases in expenses will be offset, in part, by the operator or tenant expense reimbursements and contractual rent increases described above.

### Non-GAAP Financial Measures Reconciliations

#### Funds From Operations and Funds Available for Distribution

The following is a reconciliation from net income applicable to common shares, the most directly comparable financial measure calculated and presented in accordance with GAAP, to FFO, FFO as adjusted and FAD (in thousands, except per share data):

|  | Three Months Ended September 30, 2015 | 2014 | Nine Months Ended September 30, 2015 | 2014 |
| --- | ---: | ---: | ---: | ---: |
| Net income applicable to common shares | $115,046 | $247,208 | $38,613 | $723,651 |
| Depreciation and amortization of real estate, in-place lease and other intangibles | 134,704 | 122,975 | 369,629 | 343,496 |
| Other depreciation and amortization | 5,204 | 4,769 | 17,016 | 12,571 |
| Impairments of real estate | — | — | 2,948 | — |
| Gain on sales of real estate | (52) | — | (6,377) | (28,010) |
| Equity income from unconsolidated joint ventures | (8,314) | (10,168) | (33,916) | (39,388) |
| FFO from unconsolidated joint ventures | 20,530 | 14,571 | 69,322 | 48,683 |
| Noncontrolling interests’ and participating securities’ share in earnings | 2,908 | 3,851 | 9,586 | 13,310 |
| Noncontrolling interests’ and participating securities’ share in FFO | (6,656) | (5,902) | (18,983) | (17,425) |
| FFO applicable to common shares | 263,370 | 377,304 | 447,838 | 1,056,888 |
| Distributions on dilutive convertible units | 2,365 | 3,486 | — | 10,327 |
| Diluted FFO applicable to common shares | $265,735 | $380,790 | $447,838 | $1,067,215 |
| Diluted FFO per common share | $0.57 | $0.82 | $0.97 | $2.30 |
| Weighted average shares used to calculate diluted FFO per common share | 467,772 | 465,247 | 462,302 | 464,512 |

59

|  | Three Months Ended September 30, 2015 | 2014 | Nine Months Ended September 30, 2015 | 2014 |
| --- | ---: | ---: | ---: | ---: |
| Net income applicable to common shares | $0.25 | $0.54 | $0.08 | $1.58 |
| Depreciation and amortization of real estate, in-place lease and other intangibles | 0.29 | 0.26 | 0.80 | 0.75 |
| Other depreciation and amortization and impairment of real estate | 0.01 | 0.01 | 0.04 | 0.02 |
| Gain on sales of real estate | — | — | (0.01) | (0.06) |
| Joint venture and participating securities FFO adjustments | 0.02 | 0.01 | 0.06 | 0.01 |
| Diluted FFO applicable to common shares | $0.57 | $0.82 | $0.97 | $2.30 |
| Impact of adjustments to FFO: |  |  |  |  |
| Other impairments(1) | $96,856 | $— | $617,207 | $— |
| Transaction-related items(2) | 1,538 | (31,026) | 28,973 | (23,125) |
| Severance-related charge(3) | — | — | 6,713 | — |
| Foreign currency remeasurement losses (gains) | 4,036 | — | (5,497) | — |
|  | $102,430 | $(31,026) | $647,396 | $(23,125) |
| FFO as adjusted applicable to common shares | $365,800 | $346,278 | $1,095,234 | $1,033,763 |
| Distributions on dilutive convertible units and other | 3,443 | 3,554 | 10,198 | 10,383 |
| Diluted FFO as adjusted applicable to common shares | $369,243 | $349,832 | $1,105,432 | $1,044,146 |
| Diluted FFO as adjusted per common share | $0.79 | $0.75 | $2.36 | $2.25 |
| Weighted average shares used to calculate diluted FFO as adjusted per common share | 469,590 | 465,247 | 468,320 | 464,512 |

60

|  | Three Months Ended September 30, 2015 | 2014 | Nine Months Ended September 30, 2015 | 2014 |
| --- | ---: | ---: | ---: | ---: |
| FFO as adjusted applicable to common shares | $365,800 | $346,278 | $1,095,234 | $1,033,763 |
| Amortization of market lease intangibles, net | (344) | (276) | (980) | (619) |
| Amortization of deferred compensation(4) | 5,344 | 5,461 | 18,174 | 16,467 |
| Amortization of deferred financing costs, net | 5,224 | 4,648 | 14,950 | 14,122 |
| Straight-line rents | (7,069) | (8,627) | (24,817) | (35,082) |
| DFL accretion(5) | (22,662) | (18,760) | (64,176) | (57,995) |
| Other depreciation and amortization | (5,204) | (4,769) | (17,016) | (12,571) |
| Deferred revenues – tenant improvement related | (746) | (456) | (2,137) | (1,673) |
| Deferred revenues – additional rents | 254 | 551 | 641 | 1,253 |
| Leasing costs and tenant and capital improvements | (23,212) | (17,044) | (50,879) | (44,502) |
| Lease restructure payments | 6,067 | 4,289 | 16,368 | 4,289 |
| Joint venture adjustments – CCRC entrance fees | 8,386 | 3,978 | 22,048 | 3,978 |
| Joint venture and other FAD adjustments(5) | (21,892) | (17,564) | (59,153) | (47,575) |
| FAD applicable to common shares | $309,946 | $297,709 | $948,257 | $873,855 |
| Distributions on dilutive convertible units | 3,547 | 3,486 | 10,683 | 10,327 |
| Diluted FAD applicable to common shares | $313,493 | $301,195 | $958,940 | $884,182 |
| Diluted FAD per common share | $0.67 | $0.65 | $2.05 | $1.90 |
| Weighted average shares used to calculate diluted FAD per common share | 469,590 | 465,247 | 468,320 | 464,512 |

(1) For the three months ended September 30, 2015, other impairments include: (i) $70 million related to our Four Seasons Notes and (ii) $27 million related to our equity investment in HCRMC. For the nine months ended September 30, 2015, other impairment include: (i) $478 million related to our DFL investments with HCRMC, (ii) $112 million related to our Four Seasons Notes and (iii) $27 million related to our equity investment in HCRMC.

(2) The three and nine months ended September 30, 2014, include the benefit primarily from the Brookdale Transaction, consisting of:

(i) $108 million of net gains related to the terminated leases of the HCP owned 49-property portfolio; partially offset by a

(ii) $70 million charge to write-off the existing straight-line rents and intangible other assets, net related to the terminated leases of the 49-property portfolio; and (iii) $13 million in charges for direct costs.

(3) The severance-related charge relates to the resignation of our former Executive Vice President and Chief Investment Officer.

(4) Excludes $3 million related to the acceleration of deferred compensation for restricted stock units and stock options that vested upon the resignation of our former Executive Vice President and Chief Investment Officer, which is included in the severance-related charge for the nine months ended September 30, 2015.

(5) Our ownership interest in HCRMC is accounted for using the equity method, which requires an ongoing elimination of DFL income that is proportional to our ownership in HCRMC. Further, our share of earnings from HCRMC (equity income) increases for the corresponding elimination of related lease expense recognized at the HCRMC entity level, which we present as a non-cash joint venture FAD adjustment.

### Critical Accounting Policies

The preparation of financial statements in conformity with GAAP requires management to use judgment in the application of accounting policies, including making estimates and assumptions. We base estimates on the best information available to us at the time, our experience and on various other assumptions believed to be reasonable under the circumstances. These estimates affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. If our judgment or interpretation of the facts and circumstances relating to various transactions or other matters had been different, it is possible that different accounting would have been applied, resulting in a different presentation of our consolidated financial statements. From time to time, we re-evaluate our estimates and assumptions. In the event estimates or assumptions prove to be different from actual results, adjustments are made in subsequent periods to reflect more current estimates and assumptions about matters that are inherently uncertain. A summary of our critical accounting policies is included in our Annual Report on Form 10-K for the year ended December 31, 2014 in “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations”; our critical accounting policies have not changed during 2015.

### Recent Accounting Pronouncements

See Note 2 to the Consolidated Financial Statements for the impact of new accounting standards.

## Market risk

As filed, 4,106 characters.

We are exposed to various market risks, including the potential loss arising from adverse changes in interest rates and foreign currency exchange rates, specifically the GBP. We use derivative financial instruments in the normal course of business to mitigate interest rate and foreign currency risk. We do not use derivative financial instruments for speculative or trading purposes. Derivatives are recorded on the consolidated balance sheets at fair value (see Note 21 to the Consolidated Financial Statements).

To illustrate the effect of movements in the interest rate and foreign currency markets, we performed a market sensitivity analysis on our hedging instruments. We applied various basis point spreads to the underlying interest rate curves and foreign currency exchange rates of the derivative portfolio in order to determine the change in fair value. Assuming a one percentage point change in the underlying interest rate curve and foreign currency exchange rates, the estimated change in fair value of each of the underlying derivative instruments would not exceed $8 million (see Note 21 to the Consolidated Financial Statements).

*Interest Rate Risk.* At September 30, 2015, we are exposed to market risks related to fluctuations in interest rates primarily on variable rate debt, which has been predominately hedged through interest rate swap contracts.

Interest rate fluctuations will generally not affect our future earnings or cash flows on our fixed rate debt and assets until their maturity or earlier prepayment and refinancing. If interest rates have risen at the time we seek to refinance our fixed rate debt, whether at maturity or otherwise, our future earnings and cash flows could adversely be affected by additional borrowing costs. Conversely, lower interest rates at the time of refinancing may reduce our overall borrowing costs. However, interest rate changes will affect the fair value of our fixed rate instruments. Conversely, changes in interest rates on variable rate debt and investments would change our future earnings and cash flows, but not significantly affect the fair value of those instruments. Assuming a one percentage point increase in the interest rate related to the variable-rate debt and variable-rate investments, and assuming no other changes in the outstanding balance as of September 30, 2015, net interest expense would increase by approximately $9 million, or $0.02 per common share on a diluted basis.

*Foreign Currency Risk.* At September 30, 2015, our exposure to foreign currencies primarily relates to U.K. investments in leased real estate, senior notes and related GBP denominated cash flows. Our foreign currency exposure is partially mitigated through the use of GBP denominated borrowings and foreign currency swap contracts. Based solely on our operating results for the three months ended September 30, 2015, including the impact of existing hedging arrangements, if the value of the GBP relative to the U.S. dollar were to increase or decrease by 10% compared to the average exchange rate during the quarter ended September 30, 2015, our cash flows would have decreased or increased, as applicable, by less than $1 million.

*Market Risk.* We have investments in marketable debt securities classified as held-to-maturity because we have the positive intent and ability to hold the securities to maturity. Held-to-maturity securities are recorded at amortized cost and adjusted for the amortization of premiums and discounts through maturity. We consider a variety of factors in evaluating an other-than-temporary decline in value, such as: the length of time and the extent to which the market value has been less than our current adjusted carrying value; the issuer’s financial condition, capital strength and near-term prospects; any recent events specific to that issuer and economic conditions of its industry; and our investment horizon in relationship to an anticipated near-term recovery in the market value, if any. At September 30, 2015, both the fair and carrying value of marketable debt securities was $118 million.

## Controls and procedures

As filed, 2,049 characters.

*Evaluation of Disclosure Controls and Procedures.* We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer (Principal Executive Officer) and Chief Financial Officer (Principal Financial Officer), to allow for timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934), management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

As required by Rules 13a-15(b) and 15d-15(b) of the Securities Exchange Act of 1934, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer (Principal Executive Officer) and Chief Financial Officer (Principal Financial Officer), of the effectiveness of the design and operation of our disclosure controls and procedures as of September 30, 2015. Based upon that evaluation, our Chief Executive Officer (Principal Executive Officer) and Chief Financial Officer (Principal Financial Officer) concluded that our disclosure controls and procedures were effective at the reasonable assurance level.

*Changes in Internal Control Over Financial Reporting.* There were no changes in our internal control over financial reporting during the fiscal quarter to which this report relates that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 267 characters.

There are no material changes to the risk factors previously disclosed in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2014, as updated by Part II, Item 1A of our Quarterly Report on Form 10-Q for the quarter ended March 31, 2015.

Filed Nov 3, 2015.
Source: SEC EDGAR, the filing index for accession 0001558370-15-002147. Last ingested by Listed: Nov 14, 2026, 21:09 ET. No prices; not investment advice.
